| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Department of Gastroenterology, Research Institute and 2 Department of Surgery, International Medical Center of Japan; and 3 GS platZ Co., Ltd., Tokyo, Japan
Requests for reprints: Taeko Dohi, Department of Gastroenterology, Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. Phone: 81-3-3202-7181; Fax: 81-3-3202-7364; E-mail: dohi{at}ri.imcj.go.jp.
The Sda blood group carbohydrate structure is expressed in the normal gastrointestinal mucosa. We reported previously that the expression of Sda carbohydrate structures and ß1,4-N-acetylgalactosaminyltransferase (ß1,4GalNAcT) activity responsible for Sda synthesis were remarkably decreased in cancer lesions of the gastrointestinal tract. In this study, we found that Sda antigen was expressed mainly in chief cells of normal stomach but not in cancer tissue by immunohistologic staining. In separated gastric mucosal cells, the Sda glycolipids and ß1,4GalNAcT activity were concentrated in a fraction that contained chief cells as a major population. We cloned the cDNA encoding the glycosyltransferase that catalyzes the synthesis of Sda (Sda-ß1,4GalNAcT). Introduction of this cloned cDNA into KATO III gastric or HT29 colonic cancer cell lines, which originally expressed the E-selectin ligands, sialyl Lewisx and sialyl Lewisa, resulted in a marked increase in cell-surface expression of Sda along with the concomitant total loss of both sialyl Lewisx and sialyl Lewisa. Both KATO III and HT29 cells transfected with the Sda-ß1,4GalNAcT gene showed significantly decreased adhesion to activated human umbilical vein endothelial cells when compared with mock-transfected cells. Sda determinants showed no direct binding to Siglec-3, -5, -7, and -9. These Sda-ß1,4GalNAcT-transfected cells showed strikingly reduced metastatic potential in vivo when compared with mock-transfected cells. In summary, forced expression of Sda carbohydrate determinant caused remarkable elimination of carbohydrate ligands for selectin and reduced metastasis of human gastrointestinal tract cancer cells.
This article has been cited by other articles:
![]() |
P. T. Martin, R. Xu, L. R. Rodino-Klapac, E. Oglesbay, M. Camboni, C. L. Montgomery, K. Shontz, L. G. Chicoine, K. R. Clark, Z. Sahenk, et al. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice Am J Physiol Cell Physiol, March 1, 2009; 296(3): C476 - C488. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Wang, C.-Y. Hsieh, Y.-C. Twu, and L.-C. Yu Expression of the Human Sda -1,4-N-Acetylgalactosaminyltransferase II Gene is Dependent on the Promoter Methylation Status Glycobiology, January 1, 2008; 18(1): 104 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Malagolini, D. Santini, M. Chiricolo, and F. Dall'Olio Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon Glycobiology, July 1, 2007; 17(7): 688 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, K. Chandrasekharan, J. H. Yoon, M. Camboni, and P. T. Martin Overexpression of the Cytotoxic T Cell (CT) Carbohydrate Inhibits Muscular Dystrophy in the dyW Mouse Model of Congenital Muscular Dystrophy 1A Am. J. Pathol., July 1, 2007; 171(1): 181 - 199. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |